Glaucoma & Optic Nerve DiseaseFaculty-Reviewed

Pigment Dispersion Syndrome

Definition

A condition characterized by disruption of the posterior iris pigment epithelium by zonular fibers, resulting in liberation of pigment granules that deposit on anterior segment structures including the trabecular meshwork, corneal endothelium (Krukenberg spindle), and lens.

Clinical Snapshot

Pigment dispersion syndrome (PDS) is characterized by mechanical disruption of the posterior iris pigment epithelium by zonular fibers, releasing pigment granules that circulate in the aqueous and deposit on anterior segment structures. The classic triad is Krukenberg spindle (vertical spindle-shaped pigment deposit on the corneal endothelium), radial mid-peripheral iris transillumination defects, and dense trabecular meshwork pigmentation on gonioscopy. Progression to pigmentary glaucoma occurs in approximately 35% of cases.

Epidemiology

PDS predominantly affects young (20–45 years), myopic males. It is more common in Caucasians. The risk of conversion to pigmentary glaucoma is approximately 35% over 15 years.

Pathophysiology

The posterior bowing of the peripheral iris (concave iris configuration) brings the posterior iris pigment epithelium into contact with the zonular fibers. Mechanical rubbing liberates pigment granules, which are deposited throughout the anterior segment. In the trabecular meshwork, pigment accumulation increases outflow resistance, elevating IOP. Exercise and pupillary dilation (which increase iris-zonule contact) can precipitate acute pigment release and IOP spikes.

Risk Factors

  • Young myopic males (classic demographic)
  • Caucasian ancestry
  • Concave iris configuration
  • Vigorous exercise (precipitates pigment release)
  • Pupillary dilation

Clinical Presentation

PDS is often asymptomatic. Some patients report blurred vision or halos after exercise (from acute IOP spikes). The classic triad: Krukenberg spindle on the corneal endothelium, radial mid-peripheral iris transillumination defects (best seen with retroillumination), and dense trabecular meshwork pigmentation on gonioscopy. IOP may be normal or elevated.

Diagnostic Pearls

  • Retroillumination of the iris reveals the characteristic radial mid-peripheral transillumination defects — do not miss this finding.
  • Gonioscopy is essential — dense, homogeneous trabecular meshwork pigmentation (Scheie grade 3–4) is characteristic.
  • Exercise-induced IOP spikes may be the presenting complaint — a history of blurred vision after exercise in a young myope should prompt evaluation.
  • Krukenberg spindle is the most visible sign but is not pathognomonic — it can occur in other conditions.

Differential Diagnosis

  • Pseudoexfoliation syndrome (different pigment pattern, older patients)
  • Uveitic glaucoma (inflammatory cells, not pigment)
  • Traumatic angle recession

Evidence-Based Management

PDS without IOP elevation: observation with periodic IOP monitoring and optic nerve assessment. Elevated IOP: IOP-lowering therapy as for POAG — prostaglandin analogues are first-line. Laser peripheral iridotomy (LPI) has been proposed to eliminate the pressure differential driving iris-zonule contact, but evidence for its efficacy in preventing progression is limited. Laser trabeculoplasty is effective but may cause IOP spikes in heavily pigmented angles.

Monitoring & Follow-Up

Annual IOP monitoring, optic nerve assessment, and visual field testing. More frequent monitoring if IOP is elevated or optic nerve changes are detected.

Clinical Pearls

  • Young myopic males with PDS should be counseled about the risk of progression to pigmentary glaucoma — lifelong monitoring is appropriate.
  • Exercise-induced IOP spikes are a real phenomenon — patients should be aware that vigorous exercise may cause transient visual symptoms.
  • Laser trabeculoplasty can cause significant IOP spikes in heavily pigmented angles — use with caution and monitor closely.
  • The pigment burden in the trabecular meshwork may decrease over time as the iris-zonule contact diminishes with age — some patients "burn out."

Related Therapeutics — Clinician's Companion

  • Glaucoma Therapeutics — Prostaglandins (Clinician's Companion)

Key References

  • 1.Ritch R, et al. Pigment dispersion syndrome. Surv Ophthalmol. 1996.
  • 2.Siddiqui Y, et al. What is the risk of developing pigmentary glaucoma from pigment dispersion syndrome? Am J Ophthalmol. 2003.

This entry is an educational reference designed to support clinical reasoning and awareness. It does not constitute medical advice, establish a standard of care, or replace individualized patient assessment. Clinicians should consult current guidelines and applicable clinical resources when making patient care decisions.